CDER Meeting: Surrogate Markers of Immunity - PowerPoint PPT Presentation

1 / 18
About This Presentation
Title:

CDER Meeting: Surrogate Markers of Immunity

Description:

LPA Reactivity to HIV p24 rAg enhanced: Long Term Non-Progressors ... Time-consuming: 5-7 Days. Radioactive. Labor-intensive. Not widely available. Not standardized ... – PowerPoint PPT presentation

Number of Views:75
Avg rating:3.0/5.0
Slides: 19
Provided by: judithab
Category:

less

Transcript and Presenter's Notes

Title: CDER Meeting: Surrogate Markers of Immunity


1
CDER Meeting Surrogate Markers of Immunity
  • Presenter Judith A. Britz, Ph.D.
  • October 16, 2000

2
(No Transcript)
3
HIV Pathogenesis
  • Cellular Immune Function Tests have Prognostic
    Value
  • independent of CD4 Count
  • Up to 1 year before CD4 Count Decline
  • Progressive Loss of Function as measured by
    response to
  • Mitogens
  • Alloantigens
  • Recall Antigens

Clerici et al. 1989. J. Clin. Invest. 84
1892 Dolan et al. 1995. J. Infect. Dis.17279
4
Immune Reconstitution
  • LPA Reactivity to HIV p24 rAg enhanced
  • Long Term Non-Progressors
  • Following early treatment of acute HIV infection
  • Strengthened by treatment interruption (in some
    patients)

Rosenberg, E.S et al. 1997. Science 278
1447 Rosenberg, E.S. et al. 2000. Nature 408 523
5
Lymphoproliferation (LPA)
  • Traditional method for evaluating
  • cell-mediated immune function
  • Time-consuming 5-7 Days
  • Radioactive
  • Labor-intensive
  • Not widely available
  • Not standardized
  • Shipping impact
  • Not practical for clinical use

Betensky et al. 2000. Clin. Diag. Lab. Immunol.
7(5) 759
6
Objectives
  • Clinical Correlate of Cell-Mediated Immunity
  • 24 Hours or less
  • Non-Radioactive
  • Whole Blood or PBMCs
  • Cost Effective
  • Adaptable to Test with Multiple Antigens
  • Standardized

7
4 hours to overnight
Lymphocyte Stimulation
8
Comparison with LPA
ATP ng/mL In vitro CMI Overnight
DPM x 100 LPA assay 96 HRS
9
Reference
  • Sottong, P.R., J.A. Rosebrock, J.A. Britz, and
    T.R. Kramer. 2000.
  • Measurement of T-lymphocyte responses in whole
    blood cultured using newly synthesized DNA and
    ATP.
  • Clinical and Diagnostic Laboratory Immunology
    7(2) 307-311

10
PHA Distribution of Normal and HIV Patients
Normal
HIV
Homi Farzadegan. Johns Hopkins. 2000. IHV Meeting.
11
Measurement Of Cell Activation By Mitogens And
Recall Antigens
Therapy Changed
B.J. Loechelt, M. Chan Childrens National
Medical Center, Washington, D.C 2000. Manuscript
in Preparation.
12
Measurement Of Cell Activation By Mitogens And
Recall Antigens
B.J. Loechelt, M. Chan Childrens National
Medical Center, Washington, D.C 2000. Manuscript
in preparation
13
ATP
Cunningham-Rundles, S. and J. Cervia. Cornell
University School of Medicine. 2000. Manuscript
in preparation.
14
Wahren, B. et al. Karolinska Institute. 2000. IHV
Meeting
15
Lymphocyte Response
Cylex In Vitro CMI
Cytokine Assays
Lympho-proliferation
ATP 1/2 - 6 hours
Lymphocyte Stimulation
16
Analytical Parameters
  • Accuracy
  • Precision
  • Sensitivity
  • Specificity
  • Reproducibility
  • Stability
  • Standardization

17
AIDS Patient Management
18
Acknowledgements
  • Susanna Cunnigham-Rundles Cornell
  • Brett Loechelt George Washington
  • Homi Farzadegan Johns Hopkins
  • Britta Wahren Karolinska
  • Tim Kramer USDA
  • Peter Sottong Cylex
  • Richard Kowalski Cylex
  • Julie Woodcock Cylex
Write a Comment
User Comments (0)
About PowerShow.com